|
STX7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79830000002212E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.543660E-02 |
| Normal-vs-Stage2 |
9.929600E-02 |
| Normal-vs-Stage3 |
7.75760000015779E-07 |
| Normal-vs-Stage4 |
1.61710000945448E-09 |
| Stage1-vs-Stage2 |
5.771400E-01 |
| Stage1-vs-Stage3 |
1.117880E-02 |
| Stage1-vs-Stage4 |
7.78660000000375E-05 |
| Stage2-vs-Stage3 |
2.942000E-01 |
| Stage2-vs-Stage4 |
6.047700E-02 |
| Stage3-vs-Stage4 |
2.018400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.92850000027656E-07 |
| Normal-vs-AfricanAmerican |
1.551650E-02 |
| Normal-vs-Asian |
9.185000E-01 |
| Caucasian-vs-AfricanAmerican |
7.009800E-01 |
| Caucasian-vs-Asian |
2.799000E-01 |
| AfricanAmerican-vs-Asian |
3.117000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.57759999192587E-09 |
| Normal-vs-Female |
2.571600E-02 |
| Male-vs-Female |
2.340000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.327400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.363100E-04 |
| Normal-vs-Age(61-80Yrs) |
5.14759999958869E-07 |
| Normal-vs-Age(81-100Yrs) |
4.556200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.776200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.457400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.512200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.375600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.473600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.456400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.430800E-01 |
| Normal-vs-Grade 2 |
1.195630E-01 |
| Normal-vs-Grade 3 |
1.16089999946389E-07 |
| Normal-vs-Grade 4 |
2.46025422256935E-13 |
| Grade 1-vs-Grade 2 |
1.053010E-01 |
| Grade 1-vs-Grade 3 |
2.420400E-03 |
| Grade 1-vs-Grade 4 |
1.615510E-03 |
| Grade 2-vs-Grade 3 |
3.398300E-03 |
| Grade 2-vs-Grade 4 |
8.95340002138312E-09 |
| Grade 3-vs-Grade 4 |
1.319710E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.380800E-01 |
| Normal-vs-ccB subtype |
5.78720404931232E-11 |
| ccA subtype-vs-ccB subtype |
1.76999970236125E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.038400E-03 |
| Normal-vs-N1 |
8.598000E-03 |
| N0-vs-N1 |
4.962300E-02 |
|
|
